ABSTRACT The relationship between the dietary level of vitamin E (VE) and the immune response of broilers was studied in three experiments. Immunity was assessed as antibody production to infectious bronchitis virus (IBV), SRBC, and Brucella abortus (BA) antigens, mitogenic response to phytohemagglutinin A (PHA) and concanavalin A (Con A), cutaneous basophil hypersensitivity (CBH) to PHA, and lipopolysaccharide induction of acute-phase proteins (APP) and heterophilia. A range of VE (0, 10, 17.5, 25, 37.5, 50, 100, and 200 IU/kg) levels were supplemented to a basal diet (corn-soy) containing 10.2 IU of VE/kg. We found a dose-dependent increase in antibody production in response to attenuated IBV
INTRODUCTION
Vitamin E (VE), a fat-soluble vitamin of plant origin, is essential for the integrity and optimal function of the reproductive, muscular, circulatory, nervous, and immune systems. It is most likely that VE, like other nutritional factors, affects the development and maintenance of immunocompetence through multiple functions, by acting directly on the immune cell or by indirectly altering metabolic and endocrine parameters, which in turn influence immune function (Gershwin et al., 1985) . Although the mechanism of VE action is not fully understood, its bioactivity is mainly associated with its antioxidant potential. As an antioxidant, VE reduces free radicalinduced pathology during both normal metabolic states and inflammation. By controlling free radical production, VE affects free radical-mediated signal transduction events and ultimately modulates the expression of genes that are regulated by free radical signaling (Packer and Suzuki, 1993) . As a primary antioxidant of cell membranes, VE is particularly important for the prevention 2001 Poultry Science Association, Inc. Received for publication February 26, 2001 . Accepted for publication July 2, 2001. 1 Presented at Experimental Biology, San Francisco, CA, 1998, Abstract #4745. 2 To whom correspondence should be addressed: kcklasing@ ucdavis.edu. 1590 between 0 and 25 IU/kg of supplemented VE and no further increase at higher levels. Antibody levels to SRBC were higher in birds supplemented with 50 IU of VE/kg compared to those supplemented with 0 or 200 IU/kg of VE. Antibody production in response to BA antigens was not influenced by VE. Mitogenic responses were suppressed by supplemented VE in Experiment 1 for PHA (25 IU/kg diet) and Con A (25 and 50 IU/kg diets). CBH and APP levels were not affected by VE. Heterophilia was lowest at 50 IU/kg 6 h after lipopolysaccharide injection (Experiment 1). Our study showed that moderate (25 to 50 IU/kg) levels of VE supplementation were most immunomodulatory and that high levels were less effective.
of fatty acid peroxidation (Benedich, 1990) . Fatty acids can act as immunoregulatory molecules that mediate cellular communication, membrane fluidity and second messenger elaboration (Klasing, 1997; Watkins, 1991) , and the effect of VE on fatty acid stability may be immunoregulatory in itself. Another potential immunoregulatory mechanism of VE is the modulation of arachidonic acid metabolism via cyclooxygenase and lipoxygenase pathways (Blumberg, 1994) , which lead to the synthesis of prostaglandins and leukotrienes, respectively.
In experimental models, many parameters of the immune system, including resistance to infection, specific antibody production, number of antibody-producing cells, in vitro mitogenic responses of lymphocytes, and the phagocytic index, are altered by supplementing diets that are deficient or marginal in VE (Marsh et al., 1981; Cook, 1991; Meydani and Blumberg, 1993; Boren and Bond, 1996) . In many cases, protective immunity is increased by VE supplementation as evidenced by increased survival of chickens against Escherichia coli, Brucella abortus, Pasteurella anatipestifer (Tengerdy and Nockels, 1975) , Eimeria tenella (Colnago et al., 1984) , and Newcastle disease virus infections (Boren and Bond, , 10, 25, 50, 100, 200 0, 10, 17.5, 25, 37.5, 50, 100, 200 0, 10, 17.5, 25, 37.5, 50, 100, (NRC, 1994) requirements (10 IU/kg) impairs natural and induced antibody production to E. coli and Newcastle disease virus in chicks and turkey poults (Friedman et al., 1998) . Qureshi et al. (1993) and Marsh et al. (1981) reported that VE supplementation (100 or 250 IU/kg of diet) did not affect antibody production of chicks, although it increased the number of macrophages (Qureshi et al., 1993) . In poults, Sell et al. (1997) demonstrated no beneficial effects of 12 or 300 IU/kg of dietary VE on mortality and pathology induced by E. coli. A variety of factors such as genetic background (Yang et al., 2000) , level of stress (McIlroy et al., 1993) , and the amount of VE in the basal (control) diet may explain the heterogeneity of reported results.
Although considerable work at the cellular level extends our knowledge of the mechanistic aspects of VE and leukocyte function, the dose-response relationship between VE levels and indices of immunocompetence remains to be determined. Most dietary studies of VE have evaluated the effects of only one or two levels of VE (usually 3 to 20 times higher than the requirement) supplemented to a basal diet that was either deficient or marginal in the vitamin. Consequently, it is not possible to make recommendations on the optimum level of dietary VE for immunocompetence. Therefore, the NRC (1994) recommended levels of VE for poultry are intended to prevent deficiency symptoms related to oxidative damage or infertility and do not consider immunocompetence. Our aim was to determine the effect of a wide range of dietary VE levels on parameters of humoral, cellmediated, and innate immune responses in broilers. We examined a range from the NRC (1994)-recommended level of 10 IU/kg to 20 times this amount. Humoral immu- nity was measured as in vivo antibody production; cellmediated immunity was measured in vivo as cutaneous basophil hypersensitivity (CBH) and in vitro as lymphocyte proliferation to phytohemagglutinin A (PHA) and concanavalin A (Con A); and innate immunity was evaluated by heterophilia and production of acute-phase proteins (hemopexin and α 1 -acid glycoprotein) after lipopolysaccharide (LPS) administration.
MATERIALS AND METHODS

Animals and Animal Husbandry
Male broiler chicks vaccinated against Marek's disease virus were purchased from Peninsula Hatchery 3 or donated by Foster Farms. 4 Experimental chicks were selected from the median weight range of an approximately twofold larger population. Chicks were assigned to pens in a brooder battery with raised wire floors so that all pens had similar initial average weights. Batteries were housed in a room with controlled light (18 h light:6 h darkness), temperature, and ventilation. For 1-wk-old birds, brooder temperatures were set to 36.7 C and were decreased by 3 C each consecutive week until they reached 23 C. Feed and water were supplied ad libitum. All experimental procedures were approved by UC Davis Animal Care and Use Committee.
Diets
The basal corn-soybean meal diet was prepared according to NRC (1994) standard research reference for practical diets, except that VE was omitted from the vitamin mix. The mineral premix supplied 0.1 mg selenium/ kg. This diet contained 10.2 IU VE derived from natural sources (corn, soybean meal, and corn oil) and was considered to be marginal for meeting NRC (1994) VE requirements. The basal diet was supplemented with VE levels as described in Table 1 . VE was provided by Hoffmann-La Roche Ltd.
5 in the form of dl-α-tocopherol acetate. Dietary VE concentrations were confirmed by HPLC analysis. 6 Replicates for each diet were assigned randomly to pens.
Experimental Design
The general experimental design of the three experiments is summarized in Table 1 . The objective of the first experiment was to determine the effect of a broad range of supplemental VE levels (0, 10, 25, 50, 100, and 200 IU/kg of diet) on the following: the humoral immune response as indicated by specific antibodies to killed infectious bronchitis virus (IBV); cell-mediated immune responses as assessed by CBH and proliferation of isolated lymphocytes in response to mitogens PHA and Con A; and innate immune responses as assessed by production of the acute-phase protein hemopexin and recruitment of immune cells after exposure to LPS ( Table 1 ). The second experiment was designed to confirm the results from Experiment 1 and to include additional levels of dietary VE between 10 and 50 IU/kg of diet, where results of Experiment 1 showed the most response. The objective of the third experiment was to determine the effect of VE supplementation separately on humoral immune responses and cell-mediated immune responses in two groups of birds from the same pen, to minimize the effect of stress induced by injecting and collecting multiple samples from the same bird as was done in Experiments 1 and 2. Seven chicks per dietary replicate were used for assessment of humoral immune responses against SRBC and Brucella abortus (BA) and a different four chicks from the same pen were used for analysis of cell-mediated and innate immune responses.
Humoral Immune Response Evaluation
Analysis of Antibody Production to IBV by ELISA. Chicks were vaccinated with IBV 7 vaccine intramuscularly (Experiment 1) or intraocularly and intramuscularly (Experiment 2). For intramuscular vaccination, the vaccine was dissolved in sterile saline and mixed with incomplete Freud's adjuvant. 8 Ten vaccine units were injected intramuscularly into the right thigh of each bird. For intraocular vaccination, the vaccine was dissolved in sterile saline solution (2000 units/mL) and 10 vaccine units were delivered by micropipet in the right eye of each bird. In each experiment, one chick per pen was left unvaccinated to confirm the absence of high background levels of antibodies.
Blood was collected from the wing vein at 6 and 12 d after vaccination. Serum was isolated and stored at −20 6 CEPS Central Analytical Laboratory, University of Arkansas, Fayetteville, AR 72701. C until analyzed. Pooled samples, representative of the pen, were obtained by mixing equal volumes of serum from vaccinated birds from the same pen (n = 4, Experiment 1; n = 5, Experiment 2) and serum IgG antibody titers were determined by ELISA by using a ProFlock antibody test kit 9 according to the manufacturer's directions.
Analysis of Antibody Production to SRBC and BA Antigen by Agglutination Assay. SRBC were washed three times in PBS and diluted in PBS to 10% (vol/vol). Three chicks per dietary replicate were injected with either 0.25 mL of 10% SRBC intramuscularly into each thigh or with 0.1 mL of undiluted BA 10 (9 × 10 8 organisms/ mL) intramuscularly into one thigh. Heparinized blood was collected by venipuncture 4 and 7 d after immunization with SRBC, or 3 and 7 d after immunization with BA. Preliminary experiments indicated that these times resulted in half-maximal and maximal responses, respectively. Plasma was stored at −20 C until further analysis.
The hemagglutination assays were performed as described by Munns and Lamont (1991) for SRBC and by Nelson et al. (1995) for BA. Before analysis, complement was heat inactivated (56 C, 30 min). Each well of a 96-well plate received 0.05 mL of diluent buffer containing PBS with 0.05% BSA. The initial well received 0.05 mL of plasma, which was serially doubly diluted by transferring 0.05 mL to the next well. Then, 0.05 mL of 2% SRBC in PBS was added to each well. The plates were shaken for 1 min, incubated for 1 h (SRBC), shaken again for 1 min, incubated for 24 h at room temperature, and then scored. The agglutination titer was expressed as the log 2 of the highest titer with 50% agglutination. Similarly, 0.05 mL of BA diluted 1:10 in PBS was added to each well. For BA titers, the plates were shaken for 1 min and incubated 24 h at room temperature in a humidified chamber. Antibody titers were also determined after the treatment of samples with 0.2 M 2-mercaptoethanol for 30 min at 37 C, to inactivate IgM.
Cell-Mediated Immune Response Evaluation
Proliferation of Isolated Blood Lymphocytes in Response to PHA and Con A. Peripheral heparinized blood was obtained by venipuncture. Blood from all birds in each cage was pooled and centrifuged 1,200 × g for 10 min. The top layer of cells enriched with lymphocytes was diluted 1:4 with RPMI 1640 medium 8 containing 5% fetal bovine serum, penicillin (100 units/mL), and streptomycin (100 mg/mL). To further purify the lymphocytes, the procedure was repeated. In a preliminary experiment, the dose response of the mitogen-induced lymphocyte proliferation was determined by incubating cells with different concentrations of Con A (Canavalia ensiformis, Type III 8 ) or PHA-P (Red Kidney Bean 8 ). The PHA and Con A concentrations that gave half-maximal and maximal proliferation responses were chosen for testing experimental samples. All experimental samples were incubated in triplicate in 96-well flat-bottom plates with either PHA-P (50 or 25 µg/mL), Con A (30 or 15 µg/mL), or cell culture media (nonstimulated). The cultures were incubated at 40 C in a humidified atmosphere containing 5% CO 2 . After 48 h of incubation, cells were pulsed with 3 H-thymidine (1 µCi/well) so that the final volume per well was 0.25 mL. Cells were harvested 18 h later and the amount of radioisotope incorporated into DNA was measured by a scintillation counter.
Lymphocyte Proliferation in Whole Blood. When lymphocytes are purified from whole blood they are separated from hormones and from VE-containing lipoproteins, which might modulate in vivo responses. Therefore, in Experiment 2, we also assessed mitogen stimulated lymphocyte proliferation in whole blood. Blood was collected by venipuncture and pooled for each pen. Pooled whole blood (4 µL) and PHA-P (100 and 25 µg/mL) or Con A (100 and 15 µg/mL) were added to microtiter plates containing a final volume of RPMI 1640 medium and antibiotics. The cells were plated, incubated, harvested, and analyzed as described for isolated lymphocytes.
Cutaneous Basophil Hypersensitivity. CBH elicited in chickens by an intradermal injection of PHA-P is mediated in part by T cells. PHA-P was dissolved in sterile PBS. In preliminary studies, we compared the CBH responses at different concentrations of injected PHA-P and two sites of injection, i.e., in the featherless spot below the ear (malar apterium) and the interdigital area of the foot. CBH responses were more pronounced in the malar apterium than in the interdigital area (data not shown). PHA-P was injected into the left malar apterium (0.1 mg per bird in Experiment 2, 0.05 mg per bird in Experiment 3) and PBS was injected on the other side. The CBH response to PHA-P was evaluated by measuring the skin thickness in the injection site 12 h postinjection by using low pressure calipers. Data are reported as the difference between skin thickness of the PHA-P and the PBS-injected sites.
Evaluation of the Innate Immune Response
Birds were injected with 3 mL of Salmonella typhimurium LPS 8 (100 mg/L) intraabdominally. Heparinized venous blood was collected at 6 h (Experiment 1), 12 h (Experiment 2), and 24 h (Experiment 3) after injection. Plasma was isolated and stored at −20 C until analyzed.
Analysis of Hemopexin Production by Rocket Gel Immunoelectrophoresis. Plasma samples were run on 1% agarose gel containing 3.33% of rabbit-antichicken hemopexin antibodies in Monthony buffer (Adler et al., 2001) . Gels were stained in a solution containing 0.5% Coomassie brilliant blue dye 8 in ethanol:acetic acid:water (9:2:9) solution for 3 min and destained in acetic acid:ethanol:water (10:3:6) solution overnight (Adler et al., 2001 ). The relative concentration was evaluated by measuring 11 Saikin Kagaku Institute Co. Ltd., Japan.
the height of the precipitation peaks. The variability among different gels was accounted for by adjusting the peak height of samples to a standard plasma sample run on each gel. Data are presented as an index, i.e., the ratio of the sample concentration to the standard concentration.
Analysis of α 1 -Acid Glycoprotein Production by Single Radial Immunodiffusion. Plasma samples from chicks within each pen were pooled before analysis. α 1 -Acid glycoprotein was measured in duplicate by radial immunodiffusion by using the chicken α 1 -acid glycoprotein measurement kit 11 according to the manufacturer's instructions.
Blood Cell Counts. Blood smears were prepared by hand, air-dried, and stained with Wright Giemsa.
8 Data are presented as cell numbers as percentages of total leukocytes and also as ratios between heterophil numbers and lymphocyte numbers.
Statistical Analysis
All data were analyzed by using Minitab software by a general linear model for a one-way ANOVA using dietary VE level as the independent variable. When the main effect for dietary VE was significant (P < 0.05), individual treatment differences were determined by using Tukey's family error rate at P = 0.05. Antibody levels were analyzed by general linear model as a two-way factorial arrangement of treatments for time, dietary VE, and their interaction. Preplanned orthogonal contrasts were made by using JMP statistical package (SAS Institute, 1996) .
RESULTS
Humoral Immunity
The effect of VE on antibody production depended on the nature of the antigen. After vaccination with killed IBV (Experiment 1), antibody titers were similar on Days 6 and 12 postvaccination. There was an increase in anti-IBV titer with increasing VE to 25 IU/kg of added vitamin E ( Figure 1A , Table 2 ). Antibody levels were higher than the positive control provided by the manufacturer (indicating effective vaccination) for diets with 25, 50, 100, and 200 IU added vitamin E/kg and lower for 0 and 10 IU added vitamin E/kg.
In the second experiment, antibody titers to live IBV were significantly greater on Day 12 compared with Day 6 (P < 0.001). The level of dietary VE also affected titers ( Figure 1B ). On Day 6 postvaccination antibody titers decreased when VE was supplemented, with 10, 17.5, 25, 37.5, 50, 100, and 200 IU of added VE/kg being significantly lower than 0 IU/kg (P < 0.001). Twelve days postvaccination, titers did not decrease significantly (P = 0.063) as levels increased from 0 to 25 IU/kg added VE ( Figure 1B, Table 2 ).
In Experiments 1 and 2, IBV vaccine was chosen because it is a commonly used vaccine in commercial poultry. However, due to the differences in the antibody pro- duction profiles observed between Experiment 1 and 2, we decided that using antigens that do not replicate in vivo could allow more insight on the effect of VE on humoral immunity. Heat-killed IBV was deemed to be insufficiently immunogenic although an adjuvant was used. Thus, in Experiment 3, we evaluated the antibody production in response to SRBC and BA. Both SRBC and BA antigens are very immunogenic, do not require an adjuvant, and do not replicate in vivo. In general, SRBC antibody titers were higher at 8 d postvaccination than at 4 d. Titers generally increased as VE level increased from 0 to 50 IU/kg of added vitamin E, peaking at 50 IU/kg, and decreasing afterward ( Figure 1C , Table 2 ). Chicks fed 50 IU/kg of added VE had significantly (P < 0.05) higher SRBC antibody titers than chicks fed 0 or 200 IU added VE/kg. Antibody titers to BA, a T-cell independent antigen, were significantly higher 6 d postvaccination than at 3 d (P < 0.001), but there was no significant difference due to the level of VE in the diets (Table 2) . Average (± SD) titers were 1.48 ± 0.19 at Day 3 and 3.35 ± 0.58 at Day 7 postvaccination. The titers reported for both BA and SRBC were due to IgM (not resistant to 2-mercaptoethanol) and levels of IgG were variable and often undetectable.
Cell-Mediated Immunity
Lymphocyte Proliferation. In Experiment 1, proliferation of purified lymphocytes in mitogen-free cell culture medium (control) was not affected by the level of dietary VE fed to chicks (Table 3) . Mitogenic responses to PHA and Con A were significantly altered by VE. PHA at 25 µg/mL induced lower rates of proliferation of purified lymphocytes from chicks fed 25 compared to 0 IU/kg added VE. At 50 µg/mL PHA, proliferation was lower with 25 and 50, compared to 0 IU/kg added VE. The effect of VE on the proliferative responses to Con A were similar to those with PHA. Mitogenic responses to Con A (15 µg/mL) were decreased at 25 and 50, compared to 0 and 100 IU/kg added VE. At a higher concentration of Con A (30 µg/mL) lymphocyte proliferation was decreased with 10, 25, 50, and 200 IU added VE/kg compared to the 0 level.
In Experiment 2, proliferation of whole blood lymphocytes in the absence of mitogens was decreased with 37.5 and 50 IU/kg of added VE compared to the 0 level (Table  4) . VE levels significantly altered mitogen-induced proliferative indexes only for PHA at 25 µg/mL, where proliferation at 50 IU of added VE/kg was higher than at 100 IU/kg. This difference in index was due to differences in the proliferation of unstimulated cells as the cpm incorporated in mitogen-stimulated cells was not affected by VE (data not shown).
Cutaneous Basophil Hypersensitivity. VE levels did not affect CBH responses. The average response in Experiment 2 was 6.15 ± 0.59 mm and in Experiment 3 was 3.26 ± 0.16 mm. 
Innate Immunity
Acute-Phase Protein Production. VE supplementation did not affect plasma hemopexin levels after LPS injection. The average hemopexin index in Experiment 2 was 1.25 ± 0.04 and in Experiment 3 was 2.87 ± 0.11. There were no dietary effects on plasma hemopexin levels before LPS injection in Experiment 2 (1.27 ± 0.05); however, in Experiment 3, hemopexin levels before the LPS challenge were significantly lower (P < 0.001) with 50 and 200 IU/kg (1.32 ± 0.08 and 1.21 ± 0.08, respectively) of added VE compared with all other diets (average of 1.78 ± 0.10).
Acute-phase protein α 1 -acid glycoprotein levels were not affected by VE (Experiment 3). The average level of α 1 -acid glycoprotein among dietary groups was 386.8 ± 20.8 µg/mL. Blood Cell Counts. Blood cell profiles of chicks were not affected by dietary VE before LPS administration. At 6 h after LPS administration (Experiment 1), the percentage of heterophils in peripheral blood was the lowest (P < 0.001) at 50 IU/kg of VE (Figure 2 ).
DISCUSSION
This study was conducted to evaluate the dose-response relationship between the level of dietary VE and indices of humoral, cell-mediated, and innate immune Values (means ± SEM) in a column not sharing a superscript are significantly different (P < 0.05). responses. The level of VE affected at least one index of each of these effector arms of the immune system. Typically, an addition of between 25 and 50 IU of VE to the basal diet containing the NRC-suggested (1994) requirement of 10 IU was most immunomodulatory. Higher levels of VE were often less effective. In addition, supplemental VE increased the immune response for some indices (antibody response) and decreased the response for others (mitogen-driven proliferation, and heterophilia).
In the case of the humoral immune response, the effect of added VE depended on the nature of the antigen. With two of the three nonproliferating antigens used in these studies (killed IBV and SRBC), we observed an increase in the antibody response when VE was added to the diet and there was a nonsignificant effect (P = 0.100) for a similar response for BA. In the case of IBV, this increase occurred with 25 IU, and in the case of SRBC, it occurred at 50 IU. Further additions either had no additional value (IBV) or, in the case of SRBC, had a negative effect. It is interesting that VE clearly enhanced the response to killed IBV (Experiment 1) but impaired the response to live IBV vaccine (Experiment 2). Previously, Marsh et al. (1981) and Cook (1991) demonstrated that VE is immunoregulatory only at low antigen levels. It is possible that in our study, in vivo propagation of the live IBV vaccine could have created a higher level of antigen in Experiment 2, compared to Experiment 1 in which birds were vaccinated Values (means ± SEM) in a column not sharing a superscript are significantly different (P < 0.05). with killed virus. Alternately, the lower response to live IBV with VE supplementation could be due to greater cellmediated defenses in the supplemented groups. There is evidence that cell-mediated and local mucosal immunity play an important part in the development of immunity to IBV vaccination (Darbyshire, 1987) . If the proliferation of the IBV were diminished by VE supplementation, less of a systemic antibody response should result. Clearly, the interpretation of results arising from live vaccines is difficult. Another consideration when interpreting the differential effect of VE with live versus killed vaccines is the level of maternal antibodies. Some IBV-specific antibodies were detected in unvaccinated birds (Experiment 2). This background antibody level was significantly higher in birds fed 50 IU/kg of VE than in any other diets (data not shown). It is known that there is about 50% transfer of titer from the breeder hen to the chick (Leeson and Summers, 2000) , which can protect chickens against IBV FIGURE 2. Effect of the level of dietary vitamin E on the ratio of heterophils to lymphocytes in the blood after a challenge with lipopolysaccharide in Experiment 1 (means ± SEM). challenge for about 4 wk (Darbyshire, 1987) . It might also interfere with development of specific humoral responses to IBV by neutralizing the antigen load of the vaccine. As chicks were randomly assigned to pens, they presumably had the same initial maternal antibody titers, and effects of VE on stability of maternal Ig is a plausible explanation for the higher titer at the time that the chicks were vaccinated. If dietary VE affects the stability of maternal antibodies in chicks, it could result in differential levels of maternal antibodies to IBV that would mask the effect of dietary VE on antibody production in young chicks. Thus, in future studies, it will be desirable to evaluate the effect of VE on maternal antibody stability.
However, with all these considerations for live IBV vaccine, it is not clear what caused the reduction in antibody levels to the nonproliferating, T-cell-dependent antigen, SRBC, at high VE levels (200 IU). Although the effect of VE as a dietary and in vitro supplement has been demonstrated to alter cytokine production and CD4/CD8 T-cell radios Romach et al., 1993; Amarakoon et al., 1995; Erf et al., 1998) ; the effect of a large range of dietary VE levels was not evaluated. We suggest that high levels of dietary VE could have a dampening effect on T helper cell function or T helper cell numbers. These changes would modulate cytokine production, activation of B cells, and, ultimately, the levels of specific antibodies. Further research on effects of dietary levels of VE on these parameters is necessary.
Lymphocyte proliferation in response to mitogens is correlated with the ability of the host to mount a cellular immune response. It has been suggested that differential reactivity to mitogens reflects either maturational or functional differences in the responsive lymphocytes. We observed a large decrease in proliferation of lymphocytes in response to PHA when VE supplementation increased from 0 to 50 IU/kg if partially purified lymphocytes were used, but not when a whole blood assay was used. Conflicting results were also reported previously for mitogendriven lymphocyte proliferation in response to VE sup-plementation (Corwin et al., 1981; Kline and Sanders, 1993) . It was shown that many factors, including cell preparation, cell culture medium, and duration of the assay, might influence the effects of dietary factors on in vitro responses. Specifically, several studies demonstrated that VE becomes quickly depleted in cell cultures, and the addition of serum supplements to the media could introduce different levels of VE in in vitro experiments (Kelley et al., 1995; Leist et al., 1996) . The measurement of lymphocyte proliferation in whole blood is considered by many researchers to be a more valid measure of T-cell function than the assays with purified or isolated lymphocytes, as it preserves the lymphocyte microenvironment (Talebi et al., 1995) . Nevertheless, although we have tried to minimize the effect of in vitro conditions by decreasing cell preparation time and by using the same cell culture medium, we suspect that the long duration (3 d) of the lymphocyte proliferation assay may have contributed to the observed differences among our experiments.
Previously, we observed that stress caused by handling the birds during blood collection could influence mitogen-induced proliferation (Leshchinsky and Klasing, 1999) . Therefore, different levels of stress, either environmental or imposed by the study design, in the two experiments might have contributed to variation in mitogenic responses observed. We did not observe an effect of dietary VE on the CBH responses, an in vivo counterpart of in vitro PHA-mediated mitogenesis, and we speculate that VE might affect the in vitro lymphocyte responsiveness to mitogen by altering cell adaptation to culture conditions. However, with all of these considerations in mind, our results demonstrate that low and moderate dietary VE levels cause different responses in proliferative lymphocyte assays compared with high levels.
The inflammatory response is considered to be the cornerstone of innate immunity with heterophils and macrophages as the first lines of defense during inflammation (Cheung and Miller, 1984; Klasing, 1991) . The main mediators of inflammation are pro-inflammatory cytokines interleukin-1, interleukin-6, myelomonocytic growth factor, and tumor necrosis factor-α released by activated macrophages; these cytokines mediate changes in glucocorticoids, acute-phase proteins, and recruitment of monocytes and heterophils from the bone marrow (Klasing, 1991; Siatskas and Boyd, 2000) . The proportions of blood heterophils to lymphocytes are widely used to evaluate the presence of inflammation and have been well characterized in a variety of models of avian inflammation (Harmon, 1998) . We observed decreased heterophilia due to moderate levels of supplemental VE (50 IU/kg). Higher levels of dietary VE did not have the same effect as 50 IU/kg. VE-deficient mammals have increased production of the acute-phase proteins hemopexin and αd 1 -acid glycoprotein (Grimble, 1994) . Increases in hemopexin and α 1 -acid glycoprotein after LPS challenge is mediated by proinflammatory cytokines (Adler et al., 2001 ) including myelomonocytic growth factor (Siatskas and Boyd, 2000) . It is known that high dietary VE decreases interleukin-1β secretion in humans (Devaraj et al., 1996) and myelomonocytic growth factor mRNA expression in chickens (Leshchinsky, 2000) . Thus, we initially hypothesized that an effect of VE on proinflammatory production could result in VE-related differences in acute-phase protein production. As we did not see any diet-related differences in the acute-phase protein responses, it may be that the basal diet had sufficient VE to produce a normal release of proinflammatory cytokines.
Taken together, our experiments indicate that moderate levels of supplemental VE (25 to 50 IU/kg) modulate the immune system more than high levels (100 to 200 IU/ kg). The immunomodulatory VE levels identified in our study correspond to the VE levels necessary for the inhibition of lipid peroxidation and protection of mitochondria and microsomes of the liver against oxidative stress (Combs et al., 1975; Scott, 1980) . Free radicals are involved in the regulation of gene expression, including immunoregulatory genes under the control of transcription factors, nuclear factor-κB (NF-κB) and activator protein AP-1 (Azzi et al., 1993; Grimble, 1994) . These genes regulate a number of immunological processes including viral activation, cytokine and adhesion molecule synthesis, and acute inflammation reaction (Grimble, 1994; Sen and Packer, 1996; Lander, 1997) . Packer and Suzuki (1993) demonstrated that VE and derivatives inhibit NF-κB activation in vitro and therefore modulate expression of genes that are under NF-κB control.
If VE antioxidant properties are responsible for an immunomodulatory effect, it is not clear why high VE levels (100 and 200 IU/kg) do not have effects similar to moderate VE levels (25 to 50 IU/kg). It is known that VE works as a part of cellular antioxidant systems in the close cooperation with other cellular antioxidants, particularly the ascorbate and glutathione systems. Parts of this antioxidant system are able to regenerate each other (Packer et al., 1997) . Yang et al. (1976) reported that either a deficiency or an excess of dietary VE decreases glutathione peroxidase activity in rats and thus modulates the intracellular glutathione pool. It also has been shown that different antioxidants have differing effects on NF-κB status (Packer and Suzuki, 1993) . Thus, the dose of VE could modify the overall balance of antioxidants in a cell, resulting in differing pools of antioxidant compounds that carry different immunoregulatory properties. Alternately, VE at high concentrations can serve as a prooxidant (Thomas and Stocker, 2000) , and it may be that the highest levels used in our experiments increased free radical formation in cytosolic pools that influence leukocyte responses.
In summary, our study demonstrated that dietary VE enhances the antibody response to some antigens, dampens the proliferative response of lymphocytes to polyclonal mitogens, and lessens the heterophilia induced by LPS administration. Moderate additions of VE (25 to 50 IU/kg) affected indices of the immune response more than higher levels of supplementation (100 to 200 IU/kg). We hypothesize that moderate and high dietary levels of VE may have different effects on the cellular free radical/ antioxidant balance, which results in different signal transduction events and activation states of the immune cells.
